| Medical and Health Sciences | 2021-2025 | 76 | CN 8 | 99.98 |
| Biological Sciences | 2021-2025 | 63 | CN 24 | 99.94 |
| Environmental Science and Ecology | 2021-2025 | 654 | CN 301 | 99.39 |
| Molecular Biology | Lifetime | 895 | CN 43 | 99.52 |
| Epidemiology | Lifetime | 653 | CN 19 | 99.18 |
| Medical Physiology | Lifetime | 583 | CN 10 | 99.01 |
| Pediatrics, Perinatology and Child Health | Lifetime | 473 | CN 7 | 98.63 |
| Pulmonary and Respiratory Medicine | Lifetime | 982 | CN 21 | 98.38 |
| Complementary and Alternative Medicine | Lifetime | 370 | CN 36 | 97.98 |
| Endocrine and Autonomic Systems | Lifetime | 188 | CN 2 | 96.95 |
| Cell Biology | Lifetime | 578 | CN 9 | 96.83 |
| Nutrition and Dietetics | Lifetime | 843 | CN 59 | 95.94 |
| Health, Toxicology and Mutagenesis | Lifetime | 799 | CN 142 | 96.10 |
| Pathology and Forensic Medicine | Lifetime | 942 | CN 31 | 95.23 |
| Pollution | Lifetime | 572 | CN 149 | 95.68 |
| Obstetrics and Gynecology | Lifetime | 538 | CN 7 | 95.04 |
| Reproductive Medicine | Lifetime | 693 | CN 9 | 93.13 |
| Pharmacology | Lifetime | 683 | CN 60 | 90.52 |
| Nephrology | Lifetime | 847 | CN 30 | 86.23 |
| Molecular Biology | 2021-2025 | 39 | CN 18 | 99.85 |
| Epidemiology | 2021-2025 | 74 | CN 9 | 99.57 |
| Surgery | 2021-2025 | 218 | CN 15 | 98.68 |
| Complementary and Alternative Medicine | 2021-2025 | 44 | CN 9 | 98.26 |
| Medical Physiology | 2021-2025 | 131 | CN 6 | 98.48 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 109 | CN 46 | 98.46 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 226 | CN 36 | 98.21 |
| Pathology and Forensic Medicine | 2021-2025 | 124 | CN 9 | 97.12 |
| Biomedical Engineering | 2021-2025 | 483 | CN 273 | 97.40 |
| Public, Environmental and Occupational Health | 2021-2025 | 401 | CN 15 | 96.36 |
| Neuroscience of Neurology | 2021-2025 | 102 | CN 15 | 94.85 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 247 | CN 12 | 95.17 |
| Pollution | 2021-2025 | 223 | CN 108 | 96.37 |
| Obstetrics and Gynecology | 2021-2025 | 152 | CN 6 | 95.67 |
| Psychiatry and Mental health | 2021-2025 | 221 | CN 8 | 95.23 |
| Oncology | 2021-2025 | 422 | CN 48 | 94.91 |
| Clinical Psychology | 2021-2025 | 543 | CN 20 | 94.81 |
| Nephrology | 2021-2025 | 144 | CN 13 | 93.80 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 291 | CN 8 | 93.23 |
| Nutrition and Dietetics | 2021-2025 | 228 | CN 76 | 92.69 |
| Cell Biology | 2021-2025 | 123 | CN 13 | 89.70 |
| Clinical Neurology | 2021-2025 | 282 | CN 13 | 91.46 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 576 | CN 18 | 90.89 |
| Cancer Research | 2021-2025 | 255 | CN 72 | 85.80 |
| Cellular and Molecular Neuroscience | 2021-2025 | 222 | CN 21 | 82.80 |
| Genetics | 2021-2025 | 551 | CN 44 | 84.44 |
| Immunology | 2021-2025 | 589 | CN 123 | 83.09 |
| Clinical Pharmacology | 2021-2025 | 382 | CN 34 | 82.83 |
| Biomaterials | 2021-2025 | 525 | CN 205 | 79.89 |
| Orthopedics and Sports Medicine | 2021-2025 | 372 | CN 7 | 69.54 |
| Adipose Tissue and Metabolism | Lifetime | 218 | CN 6 | 99.37 |
| Birth, Development, and Health | Lifetime | 254 | CN 5 | 99.11 |
| Regulation of Appetite and Obesity | Lifetime | 112 | CN 3 | 99.06 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 265 | CN 6 | 98.69 |
| Metabolism, Diabetes, and Cancer | Lifetime | 484 | CN 9 | 98.23 |
| Cancer-related gene regulation | Lifetime | 687 | CN 89 | 96.87 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 345 | CN 12 | 96.25 |
| Inflammasome and immune disorders | Lifetime | 481 | CN 42 | 95.72 |
| Biochemical Analysis and Sensing Techniques | Lifetime | 917 | CN 33 | 95.65 |
| Advanced Glycation End Products research | Lifetime | 596 | CN 59 | 93.56 |
| Traditional Chinese Medicine Analysis | Lifetime | 700 | CN 504 | 91.87 |
| TGF-β signaling in diseases | Lifetime | 800 | CN 66 | 90.77 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 713 | CN 130 | 89.16 |
| Traditional Chinese Medicine Studies | Lifetime | 989 | CN 572 | 86.37 |
| Apelin-related biomedical research | Lifetime | 579 | CN 45 | 88.42 |
| Vascular Malformations and Hemangiomas | Lifetime | 929 | CN 78 | 88.74 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 916 | CN 118 | 87.38 |
| Natural Compounds in Disease Treatment | Lifetime | 324 | CN 167 | 80.43 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 6 | CN 4 | 97.54 |
| Cancer-related gene regulation | 2021-2025 | 20 | CN 15 | 97.95 |
| Gut microbiota and health | 2021-2025 | 364 | CN 169 | 97.24 |
| RNA modifications and cancer | 2021-2025 | 461 | CN 306 | 96.16 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 599 | CN 75 | 97.35 |
| Air Quality and Health Impacts | 2021-2025 | 405 | CN 218 | 97.24 |
| Autophagy in Disease and Therapy | 2021-2025 | 159 | CN 79 | 94.38 |
| Advanced Glycation End Products research | 2021-2025 | 51 | CN 23 | 92.39 |
| Epigenetics and DNA Methylation | 2021-2025 | 604 | CN 229 | 92.66 |
| Natural product bioactivities and synthesis | 2021-2025 | 182 | CN 95 | 92.40 |
| Diet and metabolism studies | 2021-2025 | 675 | CN 81 | 94.13 |
| Birth, Development, and Health | 2021-2025 | 466 | CN 52 | 93.47 |
| Tryptophan and brain disorders | 2021-2025 | 378 | CN 113 | 93.03 |
| Acute Kidney Injury Research | 2021-2025 | 175 | CN 34 | 92.61 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 528 | CN 26 | 93.33 |
| Climate Change and Health Impacts | 2021-2025 | 594 | CN 167 | 91.47 |
| Cancer Cells and Metastasis | 2021-2025 | 498 | CN 104 | 88.88 |
| Energy and Environment Impacts | 2021-2025 | 412 | CN 91 | 92.96 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 671 | CN 80 | 91.00 |
| Inflammasome and immune disorders | 2021-2025 | 451 | CN 212 | 88.57 |
| S100 Proteins and Annexins | 2021-2025 | 134 | CN 14 | 85.07 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 353 | CN 65 | 86.71 |
| Pancreatic function and diabetes | 2021-2025 | 780 | CN 45 | 88.88 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 194 | CN 78 | 86.52 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 378 | CN 92 | 86.28 |
| Mitochondrial Function and Pathology | 2021-2025 | 924 | CN 119 | 85.91 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 330 | CN 105 | 84.70 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 639 | CN 79 | 84.58 |
| Suicide and Self-Harm Studies | 2021-2025 | 629 | CN 42 | 87.45 |
| Complementary and Alternative Medicine Studies | 2021-2025 | 249 | CN 28 | 84.29 |
| Fatty Acid Research and Health | 2021-2025 | 394 | CN 83 | 81.65 |
| Spinal Cord Injury Research | 2021-2025 | 562 | CN 168 | 81.75 |
| Ovarian function and disorders | 2021-2025 | 960 | CN 229 | 82.66 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 604 | CN 144 | 77.87 |
| Biochemical Analysis and Sensing Techniques | 2021-2025 | 842 | CN 313 | 78.50 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 856 | CN 35 | 77.26 |
| Gynecological conditions and treatments | 2021-2025 | 391 | CN 59 | 77.67 |
| Alcohol Consumption and Health Effects | 2021-2025 | 821 | CN 98 | 78.02 |
| Traditional Chinese Medicine Studies | 2021-2025 | 319 | CN 233 | 73.62 |
| Ginseng Biological Effects and Applications | 2021-2025 | 619 | CN 509 | 73.75 |
| Acupuncture Treatment Research Studies | 2021-2025 | 691 | CN 461 | 72.09 |
| Cancer Mechanisms and Therapy | 2021-2025 | 996 | CN 445 | 71.08 |
| Kruppel-like factors research | 2021-2025 | 330 | CN 118 | 69.95 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 323 | CN 81 | 66.12 |
| Phagocytosis and Immune Regulation | 2021-2025 | 862 | CN 371 | 67.04 |
| Connexins and lens biology | 2021-2025 | 373 | CN 110 | 65.96 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 586 | CN 193 | 63.86 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 928 | CN 816 | 62.29 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 803 | CN 34 | 58.11 |
| Renin-Angiotensin System Studies | 2021-2025 | 461 | CN 49 | 51.84 |
| Gestational Trophoblastic Disease Studies | 2021-2025 | 401 | CN 61 | 50.79 |
| GDF15 and Related Biomarkers | 2021-2025 | 721 | CN 123 | 49.91 |
| Barrier Structure and Function Studies | 2021-2025 | 769 | CN 187 | 49.30 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 903 | CN 39 | 46.78 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 756 | CN 229 | 34.64 |